MDMB-FUBINACA

MDMB-FUBINACA
Legal status
Legal status	CA: Schedule II; DE: NpSG (Industrial and scientific use only); UK: Class B; US: Schedule I;
Identifiers
	IUPAC name Methyl (2S)-2-{[1-(4-fluorobenzyl)indazole-3-carbonyl]amino}-3,3-dimethylbutanoate;
CAS Number	1971007-93-8;
PubChem CID	119025665;
ChemSpider	32741674;
UNII	544DR70TN4;
CompTox Dashboard (EPA)	DTXSID301355877 DTXSID501010003, DTXSID301355877 ;
Chemical and physical data
Formula	C22H24FN3O3
Molar mass	397.450 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C(N[C@H](C(OC)=O)C(C)(C)C)C1=NN(CC2=CC=C(F)C=C2)C3=C1C=CC=C3;
	InChI InChI=1S/C22H24FN3O3/c1-22(2,3)19(21(28)29-4)24-20(27)18-16-7-5-6-8-17(16)26(25-18)13-14-9-11-15(23)12-10-14/h5-12,19H,13H2,1-4H3,(H,24,27)/t19-/m1/s1; Key:RFCDVEHNYDVCMU-LJQANCHMSA-N;

MDMB-FUBINACA (also known as MDMB(N)-Bz-F and FUB-MDMB) is an indazole-based synthetic cannabinoid that is a potent agonist for cannabinoid receptors and that has been sold online as a designer drug. The structure of MDMB-FUBINACA contains the amino acid, 3-methylvaline, also known as l-tert-leucine. MDMB-FUBINACA has K_i values of 1.14nM at CB₁ and 0.1228nM at CB₂ and EC₅₀ values of 0.2668nM at CB₁ and 0.1411nM at CB_2.

Legal status

Legal status	CA: Schedule II DE: NpSG (Industrial and scientific use only) UK: Class B US: Schedule I
Identifiers
IUPAC name Methyl (2S)-2-{[1-(4-fluorobenzyl)indazole-3-carbonyl]amino}-3,3-dimethylbutanoate
CAS Number	1971007-93-8
PubChem CID	119025665
ChemSpider	32741674
UNII	544DR70TN4
CompTox Dashboard (EPA)	DTXSID301355877 DTXSID501010003, DTXSID301355877
Chemical and physical data
Formula	C₂₂H₂₄FN₃O₃
Molar mass	397.450 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES O=C(N[C@H](C(OC)=O)C(C)(C)C)C1=NN(CC2=CC=C(F)C=C2)C3=C1C=CC=C3
InChI InChI=1S/C22H24FN3O3/c1-22(2,3)19(21(28)29-4)24-20(27)18-16-7-5-6-8-17(16)26(25-18)13-14-9-11-15(23)12-10-14/h5-12,19H,13H2,1-4H3,(H,24,27)/t19-/m1/s1 Key:RFCDVEHNYDVCMU-LJQANCHMSA-N